221 related articles for article (PubMed ID: 37848262)
21. Higher odds of periodontitis in systemic lupus erythematosus compared to controls and rheumatoid arthritis: a systematic review, meta-analysis and network meta-analysis.
Tan PR; Lee AJL; Zhao JJ; Chan YH; Fu JH; Ma M; Tay SH
Front Immunol; 2024; 15():1356714. PubMed ID: 38629069
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).
Scirè CA; Carrara G; Zanetti A; Landolfi G; Chighizola C; Alunno A; Andreoli L; Caporali R; Gerli R; Sebastiani GD; Valesini G; Sinigaglia L;
Clin Exp Rheumatol; 2020; 38(4):748-753. PubMed ID: 32723435
[TBL] [Abstract][Full Text] [Related]
23. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis.
Wang B; Shao X; Wang D; Xu D; Zhang JA
Autoimmun Rev; 2017 Jul; 16(7):756-765. PubMed ID: 28483543
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study.
Lai CH; Lai WW; Chiou MJ; Lin WC; Yang YJ; Li CY; Tsai LM
Ann Rheum Dis; 2016 Jul; 75(7):1350-6. PubMed ID: 26286017
[TBL] [Abstract][Full Text] [Related]
25. A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis.
Frade-Sosa B; Narváez J; Salman-Monte TC; Castellanos-Moreira R; Ortiz-Santamaria V; Torrente-Segarra V; Castellvi I; Magallares B; Reina D; Minguez S; Sallés M; Manrique de Lara MG; Ordoñez S; Riera E; Schur PH; Gómez-Puerta JA
Lupus; 2020 Sep; 29(10):1216-1226. PubMed ID: 32631205
[TBL] [Abstract][Full Text] [Related]
26. Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study.
Tsuda S; Sameshima A; Sekine M; Kawaguchi H; Fujita D; Makino S; Morinobu A; Murakawa Y; Matsui K; Sugiyama T; Watanabe M; Suzuki Y; Nagahori M; Murashima A; Atsumi T; Oku K; Mitsuda N; Takei S; Miyamae T; Takahashi N; Nakajima K; Saito S;
Mod Rheumatol; 2020 Sep; 30(5):852-861. PubMed ID: 31483178
[No Abstract] [Full Text] [Related]
27. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
[TBL] [Abstract][Full Text] [Related]
28. Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
Mok CC; Chan KL; Tse SM
Vaccine; 2022 Sep; 40(41):5959-5964. PubMed ID: 36085256
[TBL] [Abstract][Full Text] [Related]
29. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure.
Rúa-Figueroa I; Rúa-Figueroa D; Pérez-Veiga N; Anzola AM; Galindo-Izquierdo M; Calvo-Alén J; Fernández-Nebro A; Sangüesa C; Menor-Almagro R; Tomero E; Del Val N; Uriarte-Isazelaya E; Blanco R; Andreu JL; Boteanu A; Narváez J; Cobo T; Bohórquez C; Montilla C; Salas E; Toyos FJ; Bernal JA; Salgado E; Freire M; Mas AJ; Expósito L; Hernández-Beriain JA; Ibarguengoitia O; Velloso-Feijoo ML; Lozano-Rivas N; Bonilla G; Moreno M; Jiménez I; Quevedo-Vila V; Pecondón A; Aurrecoechea E; Valls E; Mouriño C; Vázquez-Rodríguez T; Pego-Reigosa JM
Semin Arthritis Rheum; 2022 Feb; 52():151946. PubMed ID: 35033377
[TBL] [Abstract][Full Text] [Related]
30. Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID-19 outcomes: Genome-wide cross trait analysis and bidirectional Mendelian randomization study.
Yao M; Huang X; Guo Y; Zhao JV; Liu Z
J Med Virol; 2023 Feb; 95(2):e28570. PubMed ID: 36762574
[TBL] [Abstract][Full Text] [Related]
31. Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis.
Morand EF; McCloud PI; Littlejohn GO
Ann Rheum Dis; 1992 Dec; 51(12):1318-21. PubMed ID: 1485814
[TBL] [Abstract][Full Text] [Related]
32. Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study.
Jiang X; Sparks J; Wallace Z; Deng X; Li H; Lu N; Xie D; Wang Y; Zeng C; Lei G; Wei J; Zhang Y
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36889799
[TBL] [Abstract][Full Text] [Related]
33. Frequency of Contraception Documentation in Women With Systemic Lupus Erythematosus and Rheumatoid Arthritis Within the Rheumatology Informatics System for Effectiveness Registry.
Clowse MEB; Li J; Talabi MB; Eudy AM; Schmajuk G
Arthritis Care Res (Hoboken); 2023 Mar; 75(3):590-596. PubMed ID: 34623033
[TBL] [Abstract][Full Text] [Related]
34. [Clinical features of patients with Rhupus syndrome].
Li ZF; Wu X; Wu LJ; Luo CN; Shi YM; Zhong Y; Chen XM; Meng XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):933-937. PubMed ID: 34650297
[TBL] [Abstract][Full Text] [Related]
35. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis.
Lauper K; Courvoisier DS; Chevallier P; Finckh A; Gabay C
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1756-1763. PubMed ID: 29609199
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting different COVID-19 outcomes in patients with systemic lupus erythematosus during the second pandemic wave of COVID-19 in China.
Liu PC; Zhang M; Li JB; Peng YL; Yu SJ; Wu R
Lupus; 2024 Apr; 33(4):357-364. PubMed ID: 38314781
[TBL] [Abstract][Full Text] [Related]
37. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
Salmon JE; Roman MJ
Am J Med; 2008 Oct; 121(10 Suppl 1):S3-8. PubMed ID: 18926167
[TBL] [Abstract][Full Text] [Related]
38. Enthesopathy in rheumatoid arthritis and spondyloarthritis: An ultrasound study.
Ebstein E; Coustet B; Masson-Behar V; Forien M; Palazzo E; Dieudé P; Ottaviani S
Joint Bone Spine; 2018 Oct; 85(5):577-581. PubMed ID: 29233691
[TBL] [Abstract][Full Text] [Related]
39. Isolation, Behavioral Changes, and Low Seroprevalence of SARS-CoV-2 Antibodies in Patients With Systemic Lupus Erythematosus or Rheumatoid Arthritis.
Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Mikkelsen S; Erikstrup C; Thomsen MK; Hauge EM; Troldborg A
Arthritis Care Res (Hoboken); 2022 Nov; 74(11):1780-1785. PubMed ID: 34057311
[TBL] [Abstract][Full Text] [Related]
40. Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus.
Bruera S; Lei X; Zhao H; Yazdany J; Chavez-MacGregor M; Giordano SH; Suarez-Almazor ME
Lupus Sci Med; 2023 Feb; 10(1):. PubMed ID: 36787921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]